摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,2-dimethyl-8-oxo-10-propyl-2H,8H-pyrano[2,3-f]chromen-5-yl 4-methylbenzenesulfonate | 303007-22-9

中文名称
——
中文别名
——
英文名称
2,2-dimethyl-8-oxo-10-propyl-2H,8H-pyrano[2,3-f]chromen-5-yl 4-methylbenzenesulfonate
英文别名
2,2-dimethyl-8-oxo-10-n-propyl-2H,8H-benzo[2,3-f]dipyranyl-5-p-methylphenylsulfate;5-(4-Toluenesulphonyloxy)-2,2-dimethyl-10-propyl-2H-pyrano[2,3-f]chromen-8-one;2,2-Dimethyl-5-tosyloxy-10-propyl-2H,8H-benzo[1,2-b:3,4-b']dipyran-8-one;(2,2-Dimethyl-8-oxo-10-propyl-pyrano[2,3-h]chromen-5-yl) 4-methylbenzenesulfonate;(2,2-dimethyl-8-oxo-10-propylpyrano[2,3-f]chromen-5-yl) 4-methylbenzenesulfonate
2,2-dimethyl-8-oxo-10-propyl-2H,8H-pyrano[2,3-f]chromen-5-yl 4-methylbenzenesulfonate化学式
CAS
303007-22-9
化学式
C24H24O6S
mdl
——
分子量
440.517
InChiKey
WVMIAZPMJQAILC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    150-151 °C
  • 沸点:
    615.7±55.0 °C(predicted)
  • 密度:
    1.263±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    5.2
  • 重原子数:
    31
  • 可旋转键数:
    5
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.29
  • 拓扑面积:
    87.3
  • 氢给体数:
    0
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Chemical Library and Structure–Activity Relationships of 11-Demethyl-12-oxo Calanolide A Analogues as Anti-HIV-1 Agents
    摘要:
    (+)-Calanolide A (1) 作为一种天然产物,先前被发现是HIV-1逆转录酶的抑制剂。在我们对其模板的进一步研究中,外消旋的11-去甲基-12-酮基calanolide A (15) 被发现。与(+)-calanolide A相比,它在C-11和C-12位上少两个手性碳中心,但其对HIV-1的抑制活性相当,并且具有更好的治疗指数(EC(50) = 0.11 μM,TI = 818)。随后,基于其结构核心设计并合成了一个化合物库,并在本文中引入了九个多样性点。体外评估抗HIV-1活性得出了它们的结构-活性关系(SARs)。发现了一个新的化合物(10-溴甲基-11-去甲基-12-酮基calanolide A,123),其对HIV-1的抑制效力和治疗指数(EC(50) = 2.85 nM,TI > 10,526)显著高于该类化合物。这一发现提供了非常重要的线索,即对C环的C-10位进行修饰,可能会得到对HIV-1活性更好的药物候选物。
    DOI:
    10.1021/jm701405p
  • 作为产物:
    参考文献:
    名称:
    A novel synthesis of 5-hydroxy-2,2-dimethyl-10-propyl-2H-pyrano[2,3-f]chromen-8-one
    摘要:
    A concise synthesis of 5-hydroxy-2.2-dimethyl-10-propyl-2H-pyrano[2.3-f]chromen-8-one utilising a novel selective desulfonylation protocol is described. This method provides facile access to a key intermediate for the asymmetric synthesis of calanolide A. (C), 2002 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0040-4039(02)00428-8
点击查看最新优质反应信息

文献信息

  • Novel coumarin and chromene compounds and methods of preparation and use thereof for treating or preventing viral infections
    申请人:——
    公开号:US20030176494A1
    公开(公告)日:2003-09-18
    The present invention relates to methods of preparation and use of coumarin and chromene compounds for treating or preventing viral infections.
    本发明涉及制备和使用香豆素和咖啡因类化合物用于治疗或预防病毒感染的方法。
  • Process for the preparation of calanolide precursors
    申请人:Chirotech Technology, Inc.
    公开号:US06313320B1
    公开(公告)日:2001-11-06
    The present invention concerns compounds of the formula wherein R1, R2, R3, R4 and R6 each represent H or an organic group of up to 20 C atoms, or any pair of R2 and R3 or R2 and R6 or R4 and R6 forms a cyclic group, and R5SO2 is a cleavable protecting group in which R5 is an organic group of up to 20 C atoms. These compounds are useful as intermediates in the synthesis of calanolide A and related antiviral compounds.
    本发明涉及以下式的化合物,其中R1,R2,R3,R4和R6分别代表H或最多20个C原子的有机基团,或者任何一对R2和R3或R2和R6或R4和R6形成一个环状基团,而R5SO2是一个可断裂的保护基团,其中R5是最多20个C原子的有机基团。这些化合物可用作卡拉诺利德A及相关抗病毒化合物的合成中间体。
  • TETRACYCLIC DIPYRANO-COUMARIN COMPOUNDS WITH ANTI-HIV AND ANTI-MYCOBACTERIUM TUBERCULOSIS ACTIVITIES
    申请人:Liu Gang
    公开号:US20100324067A1
    公开(公告)日:2010-12-23
    The present invention relates to tetracyclodipyrano-coumarin compounds of general formula (I), wherein the substituents are defined herein. These compounds exihibit dual biological activities of anti human immunodeficiency virus type 1 (HIV-1) infection and anti- Mycobacterium Tuberculosis (TB) infection.
    本发明涉及通式(I)的四环二吡喃香豆素类化合物,其中取代基在此定义。这些化合物表现出抗人类免疫缺陷病毒类型1(HIV-1)感染和抗结核分枝杆菌(TB)感染的双重生物活性。
  • US6313320B1
    申请人:——
    公开号:US6313320B1
    公开(公告)日:2001-11-06
  • Chemical Library and Structure–Activity Relationships of 11-Demethyl-12-oxo Calanolide A Analogues as Anti-HIV-1 Agents
    作者:Tao Ma、Li Liu、Hai Xue、Li Li、Chunyan Han、Lin Wang、Zhiwei Chen、Gang Liu
    DOI:10.1021/jm701405p
    日期:2008.3.13
    (+)-Calanolide A (1) as a natural product was previously found as an inhibitor of HIV-1 reverse tratiscriptase. In our further investigation of its template, racemic 11-demethyl-12-oxo calanolide A (15), which had two fewer chiral carbon centers at the C-11 and C-12 positions than (+)-calanolide A, had a comparably inhibitory activity and better therapeutic index (EC(50) = 0.11 mu M, TI = 818) against HIV-1 in vitro. A library based on its structural core was then designed and synthesized with introduction of nine diversity points in this article. The evaluations of anti-HIV-1 activity in vitro concluded their structure-activity relationships (SARs). A novel compound (10-bromomethyl-11-demethyl-12-oxo calanolide A, 123) was identified to have much higher inhibitory potency and therapeutic index (EC(50) = 2.85 nM, TI > 10,526) than those of the class compound against HIV-1. This finding provided a very important clue that modifications of the C ring at the C-10 position may be conducted to obtain drug candidates with better activity against HIV-1.
    (+)-Calanolide A (1) 作为一种天然产物,先前被发现是HIV-1逆转录酶的抑制剂。在我们对其模板的进一步研究中,外消旋的11-去甲基-12-酮基calanolide A (15) 被发现。与(+)-calanolide A相比,它在C-11和C-12位上少两个手性碳中心,但其对HIV-1的抑制活性相当,并且具有更好的治疗指数(EC(50) = 0.11 μM,TI = 818)。随后,基于其结构核心设计并合成了一个化合物库,并在本文中引入了九个多样性点。体外评估抗HIV-1活性得出了它们的结构-活性关系(SARs)。发现了一个新的化合物(10-溴甲基-11-去甲基-12-酮基calanolide A,123),其对HIV-1的抑制效力和治疗指数(EC(50) = 2.85 nM,TI > 10,526)显著高于该类化合物。这一发现提供了非常重要的线索,即对C环的C-10位进行修饰,可能会得到对HIV-1活性更好的药物候选物。
查看更多